Director, EU Market Access, Pricing & Policy

At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

At Genmab, we are committed to building extra[not]ordinary futures together by developing innovative antibody-based therapies that transform the lives of patients and redefine cancer treatment and other serious diseases. Our people are impact-driven, candid, and caring, and our business is rooted in science and innovation. We take pride in being unique, determined to be our best, and always authentic—values that are critical to fulfilling our purpose​.

The Role

The Director Market Access, Pricing & Policy, Europe will be responsible for driving and executing market access, reimbursement, and pricing strategies across Europe to optimize patient access to Genmab’s innovative therapies. This role requires deep expertise in payer engagement, health technology assessments (HTA), and pricing negotiations, combined with the ability to strategically navigate access challenges in a complex and evolving healthcare landscape.

The ideal candidate will be a proactive problem-solver, creative thinker, and resilient leader, capable of building relationships with payers, developing innovative access models, and driving internal alignment on access priorities. The Director will work closely with cross-functional teams and play a pivotal role in securing market access across key European countries.

This position is based in Munich, Copenhagen or Utrecht and will report to the Senior Director Global Access and Pricing.

Key Responsibilities

Direct Payer Engagement & Negotiations

• Lead pricing and reimbursement submissions to national health authorities, payers, and hospital stakeholders across key European countries, ensuring alignment with Global market access and pricing strategies
• Develop innovative pricing and contracting strategies, including value-based agreements, risk-sharing models, and managed entry agreements
• Lead pricing negotiations, ensuring alignment with payer requirements and demonstrating the value of Genmab’s assets
• Foster strong relationships with payers, health authorities, and private insurers to ensure optimal market access conditions

Pricing & Reimbursement Strategy Development

• Act as the primary point of contact for all European Market Access strategic initiatives, projects, and activities
• Communicate the EU specific market access needs and ensure they are well captured in the Global Market Access plan; provide input into JCA strategy and Genmab portfolio development
• Develop and execute market access strategies to secure timely reimbursement, optimal pricing, and broad patient access across Europe
• Identify and share best practices across European markets, fostering collaboration and continuous improvement within the Global Market Access and Pricing team

Public & Government Affairs Advocacy

• Engage with trade associations, policymakers, and industry alliances to shape an optimal European access and pricing environment​
• Monitor and provide guidance on the European market trends, policy shifts, and competitive dynamics to inform strategic adjustments and ensure Genmab is well-positioned in the evolving European market access landscape
• Advocate for patient access to innovative oncology treatments through public affairs initiatives and strategic collaborations
• Develop and drive public policy positions and strategies, ensuring alignment with Genmab’s broader business, financial, and planning processes

HEOR & Value Demonstration Integration

• Work closely with HEOR (CORE) team to ensure the development of robust economic models and evidence-generation strategies for pricing and reimbursement submissions
• Provide strategic input into real-world evidence (RWE) and outcomes research, ensuring alignment with EU payer requirements
• Lead the adaptation of global value dossiers to meet country-specific HTA and payer needs and maximize Genmab’s assets value demonstration

Requirements

• Advanced degree in Health Economics, Public Health, Health Policy, Life Sciences, or a related field (PhD, PharmD, MD, or MSc preferred),
• 10+ years of experience in market access, pricing, and policy, with a strong focus on European healthcare systems and reimbursement pathways,
• Hands-on experience in payer negotiations, HTA submissions, and pricing strategy development in European countries (at least Germany, France, UK, Spain and Italy; other countries are a plus),
• Proven ability to implement non-traditional access solutions and best practice sharing,
• In-depth knowledge of European policy trends, tactics, and HTA/payer dynamics,
• Proficient in engaging with government affairs stakeholders, trade associations, and HTA agencies to shape policy and market access conditions,
• Experience in making market access recommendations on products in development and suggesting changes for optimization of market access,
• Demonstrated success in managing multiple activities (both "self" and through delegation) and working in a fast-paced environment,
• Established network with European trade associations, policymakers, and industry alliances,
• Fluency in English is required; additional European languages are a plus.

​

Moreover, you meet the following personal requirements:

• Good interpersonal skills, including communication, presentation, teamwork, persuasion, and influence,
• Strategic Thinking & Problem-Solving, willingness to tackle unfamiliar challenges head-on and think creatively to drive innovation,
• Strong communication skills—both oral and written—with the ability to influence cross-functional teams and external stakeholders,
• Good sense of quality combined with personal drive and a positive attitude,
• Demonstrable multitasking, project management, and execution skills,
• Ability to prioritize and work in a fast paced and changing environment,
• Demonstrated ability to collaborate with a diverse group of internal and external stakeholders,
• You are result- and goal-oriented and committed to contributing to the overall success of Genmab.

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. 

Our commitment to diversity, equity, and inclusion

We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website. 

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.